Chloroquine and Lopinavir (COVID-19 Drug Candidates) Signal Amplification by Reversible Exchange

02 April 2020, Version 1
This content is a preprint and has not undergone peer review at the time of posting.


To overcome the recent coronavirus pneumonia (COVID-19), several drug candidates are suggested and tested for the latest clinical treatment. Chloroquine and lopinavir are showing definite effects after treatment. To understand more about those roles in molecular level and future application on NMR/MRI, hyperpolarization technique can open new opportunities in the diagnosis and biomedical researches to cope with COVID-19. SABRE-based hyperpolarization studies on those two drug candidates are carried out and we observed hyperpolarized proton signals from the whole structures, which can be possible by unprecedented long-distance polarization transfer by para-hydrogen. Base on this result, future work on isotope labeling, and further polarization transfer on long T1 time nuclei including clinical perspectives will open a new door for overcoming this dreadful catastrophe.


SABRE Hyperpolarization Nuclear spin-induced
hyperpolarization technique
NMR spectrometry


Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.